Metastatic breast cancer is a disease with a high mortality rate. Taxanes, a precise class of chemotherapeutic agents including Taxol® and Taxotere® have been demonstrated to be effective in tumor manage and symptom relief in metastatic breast cancer patients. Even so, it was unclear whether or not there is a advantage in survival compared to non-taxane compounds. This study evaluated the impact of taxanes inside the clinical setting for the duration of patients’ individual courses of sequential treatm
List Cost: $ 61.00
Value: [wpramaprice asin=”3639209702″]
Leave a Reply
You must be logged in to post a comment.